(2S,3S)-1-(4-tert-butylphenyl)-3-[[3-[2-[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid

InChIKey	`LPCDOMMRICKOBC-JDXGNMNLSA-N`
Compound Name	(2S,3S)-1-(4-tert-butylphenyl)-3-[[3-[2-[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid
Canonical SMILES	`COc1cccc(-c2nc(CCOc3cccc(C[C@@H]4C(=O)N(c5ccc(C(C)(C)C)cc5)[C@@H]4C(=O)O)c3)c(C)o2)c1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	6.48
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P37231	PPARG	Homo sapiens	Human	PF00104 PF12577 PF00105	7.0	IC50	ChEMBL;BindingDB
Q07869	PPARA	Homo sapiens	Human	PF00104 PF00105	6.3	IC50	ChEMBL;BindingDB
P11712	CYP2C9	Homo sapiens	Human	PF00067	6.2	IC50	ChEMBL;BindingDB